VerifiedBiotechnology Research· Founded 2016

Cartesian Therapeutics

Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis with plans to initiate a Phase 2 trial in myositis. For more information, please visit

7-day free trial · no credit card

Frederick, United States90(51 to 200)2016cartesiantherapeutics.com LinkedIn

Verified contacts

77

available on Kipplo

LinkedIn employees

90

51 to 200 range

Open roles

—

no listings

Distinct roles

51

indexed titles

Tech stack

1

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 77 verified contacts at Cartesian Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

77 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 77 verified contacts

Top roles at Cartesian Therapeutics

51 distinct titles indexed · top 10 shown.

2cell therapy specialist
2chief scientific officer
2clinical research associate
2director, qc microbiology
2quality compliance manager
2senior consultant
2senior quality assurance operations specialist
1(')
1()
1,,
+41more titles

Sign up to unlock all 77 contacts at Cartesian Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 77 verified contacts at Cartesian Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Cartesian Therapeutics | Kipplo Discover